Objective: To examine the effect of L-tryptophan administration on subjective and objective measures of fatigue in healthy volunteers. Subjects: Six healthy volunteers (4M:2F) were recruited from staff and students at the College. Setting: Department of Human Nutrition, St. Bartholomews and the Royal London School of Medicine and Dentistry. Design: Subjects were tested for central and peripheral fatigue using a visual analogue scale,¯icker fusion frequency, grip strength, reaction time and wrist ergometry. In addition, plasma free tryptophan concentrations and Trp:LNAA ratio were determined. Measurements were made before, and at 1, 2, 3 and 4 h after drinking one of two test drinks. The drinks were of either caffeine free diet Coca-Cola (placebo) or caffeine free diet CocaCola plus L-tryptophan (30 mg/kg: active drink). Each of the six subjects was tested after placebo and active drink with a one week washout period between test days. Results: Subjective fatigue was signi®cantly increased following tryptophan compared to placebo (P`0.002), and objective measures of central fatigue were signi®cantly increased by tryptophan compared to placebo (¯icker fusion frequency: P`0.001; reaction time P`0.001). No signi®cant changes in grip strength were found following tryptophan compared to placebo, but a signi®cant increase in ergometric work output was seen (P`0.001). Conclusion: Tryptophan ingestion in the quantity 30 mg/kg leads to increased subjective and central fatigue. Increases in work output observed following tryptophan may be as a result of a reduced perception of discomfort during ergometry.
Introduction
We have previously investigated the effect of dietary macronutrient manipulation on measures of fatigue and plasma amino acids (Cunliffe et al, 1997a) . We have shown that we can demonstrate increases in fatigue as the working day progresses (Cunliffe et al, 1997b) and in relation to meals of varying composition (Cunliffe et al, 1997a) . Central and peripheral fatigue measurements were not always coincident with each other. A diet induced rise in the ratio of free plasma tryptophan to competitor large neutral amino acids (Trp:LNAA) has been implicated in the genesis of central fatigue (Fernstrom, 1994) . Rises in this ratio allow more tryptophan to enter the brain and a consequent increase in 5-HT synthesis to occur.
This study was designed to investigate the effect of a placebo, and a simple metabolic intervention expected to increase fatigue. Tryptophan administration (2 g) has previously been shown to induce drowsiness in healthy volunteers (Thorleifsdottir et al, 1989) and when given in the quantity 50 mg/kg increase reaction time relative to tyrosine (Lieberman et al, 1985) . Much of the work on tryptophan has employed self ratings of mood and vigour and it was therefore decided to test tryptophan against a placebo with our newly developed range of tests for fatigue to assess if the aspects of fatigue being measured would, as in our previous investigations, be differentially affected. To further investigate and clarify the functional outcomes of changes in plasma free amino acids, the present investigation aimed to assess the effect on fatigue and plasma amino acids of the ingestion of L-tryptophan itself.
Methods
Six healthy volunteers (students and staff aged 24 ±35 y; M:F 4:2) were recruited from within the college with a mean age of 30.5 ( AE 3.9) y and mean BMI of 23.5 ( AE 1.6) kg/m 2 . The following methods were used for measuring fatigue; (1) Visual analogue scale (13 item) Ðmeasuring subjective impressions of fatigue; (2) Flicker Fusion Frequency (FFF) Ð objective measure of central fatigueÐ the¯icker rate was started at 200 Hz and reduced gradually until the subject reported seeing¯icker. Increasing fatigue is accompanied by reductions in FFF score, namely, perception of icker is detected at a lower number of cycles per second when fatigued; (3) Simple Visual Reaction TimeÐ objective measure of central fatigue Ðslowing of reaction time indicating increased central fatigue. Reaction time to a colour change on a computer screen was measured in seconds/1000; (4) Grip StrengthÐ objective measure of peripheral fatigue (brief maximal voluntary contraction) using a hand dynamometer Ðgrip strength was measured in kg force; (5) Wrist ergometry Ð objective measure of peripheral fatigue (endurance) Ðsubjects raised and lowered a ®xed weight (1.5 kg females, 2.0 kg males) in time with a metronome (69 beats per minute) until they could no longer continue. Total work done was calculated in Joules.
A more detailed description of these techniques has been given in our previous investigation (Cunliffe et al, 1997a) . A 5 ml blood sample was also taken from each subject before receiving the drink and then at each test interval. Unmarked bottles and drinking vessels were used and the subjects were unaware of which drink was being given. 200 ml of the diet cola used contains less than 1 kcal energy. Blood samples were analysed for plasma free amino acids using HPLC (Cunliffe et al, 1997a) .
Subjects were fasted overnight before testing and instructed to take only water on the morning of the test. Any subject who had not complied with the fast or who had had less than 5 h sleep was excluded. Testing began between 9.30 am and 10.00 am in all cases. Each subject was tested for fatigue, before and then at hourly intervals for 4 h after being given either the placebo drink (200 ml caffeine free diet Coca-Cola) or the active drink (200 ml caffeine free diet Coca-Cola plus L-tryptophan (SHS, Liverpool, England) in the quantity 30 mg/kg body weight). After a one week (minimum) washout period, each subject was re-tested before and at hourly intervals for 4 h after having received either the active drink (if previously having had placebo) or placebo (if previously having had active drink). A 70 kg subject given 30 mg/kg tryptophan received 2.1 g tryptophan, representing 8.4 kcals. We considered it very unlikely that this amount of energy intake would measurably affect subject performance. Between tests subjects worked as normal. For the subjects in this study, this represented light administrative work or study.
Ethical approval for all the test procedures on healthy volunteers was granted by the East London and City Health Authority.
Data analysis
Data for fatigue tests are expressed for each hourly test as the percentage changes from initial pre-test drink readings onwards through the test period and presented graphically. Error bars show standard error of the mean. The general linear model of the analysis of variance (2 way analysis of variance) was carried out to determine the effect of supplementation on the different tests (time and diet were used as factors in the model). A one way analysis of variance was performed to assess the effect of time on each measure individually. The actual baseline readings and units are also given for reference. Data for the plasma amino acids is tabulated giving plasma free tryptophan levels, tryptophan to competitor large neutral amino acid ratios (Trp:LNAA) and summed levels of the competitor large neutral amino acids ( S tyrosine, phenylalanine, valine, leucine, isoleucine).
Results Figure 1 shows that following tryptophan, mean subjective fatigue scores increased over the ®rst 3 h of the test by about 100% from pre-test drink values and in the ®nal hour increased markedly by more than another 100%. Following Figure 1 Mean percentage change from baseline (pre-drink) for subjective fatigue measured by VAS: Vertical bars show standard error. The baseline before the Tryptophan test drink was 2.13 AE 0.77 (cm) and before the Placebo test drink was 1.45 AE 0.34 (cm). * 2-way ANOVA Tryptophan vs Placebo P`0.002.
A placebo controlled investigation
A Cunliffe et al placebo on the other hand no appreciable increases in subjective fatigue score were observed until the ®nal hour of the test when the mean increase was 44% from baseline. A signi®cant difference was found (P`0.002) with respect to test drink and a signi®cant effect of time was found overall (P`0.02). The results from¯icker fusion frequency (Figure 2 ) showing mean decreases in¯icker fusion frequency scores in subjects taking tryptophan indicate that central fatigue also increased signi®cantly as measured by this objective test (P`0.001), compared to those taking placebo. Decreases in FFF score (Figure 2 ) following the tryptophan test drink and increases in FFF score following the placebo test drink were evident at the ®rst test interval (post tryptophan reduced by 4.5% and post placebo increased by 4.2%) and maintained at 4 h. A similar divergence was noted in reaction times (Figure 3 ), another measure of central arousal, which were signi®cantly increased (slowed) following tryptophan (P`0.001) when compared to placebo, which produced mean decreases in reaction time (faster reactions) at each test interval. The greatest differential between effects post tryptophan and post placebo was found at the ®rst hourly test for¯icker fusion frequency and at the third hour for reaction time. No signi®cant effect of time alone was found for either objective test of central fatigue.
No signi®cant differences were found between test drinks in the grip strength test of brief maximal voluntary contraction (Figure 4) . Work output during wrist ergometry however ( Figure 5 ) was signi®cantly greater following tryptophan (P`0.001) compared to placebo and maintained above baseline throughout the test period. While this only represented an overall mean increase of about 4%, an overall mean decrease of nearly 10% was seen following placebo. Post tryptophan, an increase in ergometric work output of just over 6% above baseline was seen at 1 h though by the second test this was reduced to a 4% increase and then maintained at about this level till the ®nal test. Following placebo, work output dropped to 7 17.5% by 2 h and was improved only to 7 12% below baseline by the ®nal test. No signi®cant effect for passage of time alone was found for the grip strength or wrist ergometry tests.
Data from analysis of blood samples shows that at baseline, no signi®cant differences were found in plasma free tryptophan, Trp:LNAA, or LNAAs. Following tryptophan ingestion there was a signi®cant increase in plasma free tryptophan compared to placebo (Table 1 : P`0.002), the placebo drink leading to a decrease in plasma levels of this amino acid. During the test, the Trp:LNAA ratio was signi®cantly raised in the plasma samples from those subjects given the drink containing tryptophan (Table 1 : P`0.002) compared to placebo. With respect to LNAAs no signi®cant difference was found between tryptophan and placebo or as a result of time alone, indicating that rises in the Trp:LNAA observed post tryptophan were as a result of increasing plasma levels of free tryptophan
The increase in plasma free tryptophan peaked at 2 h (219 mM), declining to 50 mM at 4 h. The greatest percentage increase in the Trp:LNAA was seen at 2 h from baseline and peaked at over 129% increase from baseline by 2 h from baseline. By 4 h however following tryptophan ingestion the Trp:LNAA was actually reduced to 19% below baseline, almost exactly the same percentage change as the mean value post placebo at 4 h. The placebo itself led to decreases in the Trp:LNAA at each time interval, the lowest point being 7 50% of baseline at 3 h, with a 
A Cunliffe et al mean overall decrease of 7 28% from baseline compared to a mean overall increase of 50% post tryptophan.
Discussion
The results from this study con®rm the ®ndings of other researchers (Thorleifsdottir et al, 1989; Yuwiler et al, 1981) that tryptophan administration can lead to increases in subjective sensations of fatigue. The results from thē icker fusion frequency and reaction time tests, objective measures of central fatigue, also support the notion that tryptophan can have centrally fatiguing effects that can be objectively assessed. While no signi®cant difference in the effects of the test drinks was noted in grip strength, subjects performed signi®cantly better during the ergometry test for endurance following tryptophan than following placebo. This may be a result of increased subject compliance or tolerance to discomfort due to the tryptophan administration as serotonin has been implicated in both the determination of pain threshold and the behavioural response to painful stimuli (Seltzer et al, 1981) .
With respect to voluntary muscle function it is interesting to note that at 2 h post test drink, mean increases in work done during ergometry were near peak level following tryptophan and at their nadir following placebo (point of the largest differential between test drinks; b 21%). The greatest divergence in grip strength performance following test drinks was also seen at 2 h though this time in the opposite direction (post tryptophan grip strength Figure 5 Mean percentage change from baseline (pre-drink) for Ergometry: Vertical bars show standard error. The baseline before the Tryptophan test drink was 487.6 AE 37.0 (J) and before the Placebo test drink was 558.6 AE 56.2 (J). * 2-way ANOVA Tryptophan vs Placebo P`0.001. A mean increase in plasma free tryptophan occurred following tryptophan ingestion. This would be expected as would the increase in the Trp:LNAA that was observed following the ingestion of pure tryptophan, leading to the introduction of the amino acid into the bloodstream following absorption. While an increase in free tryptophan was seen following tryptophan ingestion, a mean decrease occurred following placebo, consistent with the metabolic utilisation of the amino acid already present in plasma following a protein and energy free meal. The Trp:LNAA peaked at 2 hours (130% increase) following the tryptophan test drink and was actually reduced by 4 h. This increase is pronounced when compared to the 19% rise in the Trp:LNAA brought about by the ingestion of 1672 kJ pure carbohydrate in our previous study (Cunliffe et al, 1997a) . Given that under normal conditions tryptophan hydroxylase (rate limiting enzyme in the tryptophan to 5-HT synthetic pathway), is unsaturated, (Growdon & Wurtman, 1979) , the large increase in the Trp:LNAA seen in this study would allow for increased central 5-HT synthesis and as a consequence in increased brain tryptophan uptake. The increases in subjective and central fatigue measured were maintained at 4 h post ingestion, suggesting that while 5-HT synthesis may be increased as a result of the raised Trp:LNAA that the actual release of the neurotransmitter may persist for some time after substrate for its synthesis is depleted. While the continued rise in VAS score was signi®cant in itself over time following the tryptophan test drink, the magnitude of the increase at 4 h post test drink (216%) was over twice that seen at the same interval in a previous study of diurnal changes in fatigue in normal subjects (Cunliffe et al, 1997b) .
The ingestion of tryptophan therefore seems to have centrally and subjectively fatiguing effects. The effects on ergometry performance however suggest that the relationship between subjective reports of fatigue and voluntary muscle function capacity is a complex one. This study into the effects of supplemental tryptophan (in the quantity 30 mg/kg) con®rmed the ®ndings of other studies in terms of increases in subjective fatigue following ingestion (Koella, 1969; Hartmann, 1986) . The clear effects of tryptophan compared to placebo on subjective reports, icker fusion frequency and reaction time were accompanied by large and signi®cant rises in the tryptophan to competitor large neutral amino acid ratio. These ®ndings support the hypothesis that increased precursor availability (tryptophan) may cause central fatigue by increasing 5-HT in the brain (Newsholme et al, 1992) . Interestingly work output during ergometry was signi®cantly enhanced compared to placebo, a ®nding similar to that of (Segura & Ventura, 1988) though in contradiction to (Wilson & Maughan, 1992) who observed decreases in exercise time to exhaustion. The differences in ®ndings in studies of this type may be as a result of the precise nature of the exercise undertaken or the method by which central 5-HT increases are induced. Segura & Ventura, 1988 used dietary supplements of L-tryptophan as did the present study, whereas Wilson & Maughan, 1992 administered Paroxetin, a serotonin re-uptake inhibitor. Time of day of exercise is also infrequently reported in such studies.
It seems that tryptophan administration is centrally and objectively fatiguing but that this is associated with an increased tolerance to discomfort. Given that no increases in grip strength performance were noted following tryptophan it seems that changes to the discomfort threshold during wrist ergometry were probably responsible for the signi®cant increases in work output observed. This is consistent with the idea that endogenous opioid-induced analgesia depends on an increase in the uptake of tryptophan to the brain (Kelly & Franklin, 1985) , a greater amount of free tryptophan being available would then enhance this effect.
Conclusions
Increases in Trp:LNAA were associated with increases in subjective and objective measures of central fatigue similar though more pronounced than those seen following pure carbohydrate ingestion (Cunliffe et al, 1997a) . This implies that central fatigue may be in¯uenced by changes in the plasma Trp:LNAA and 5-HT synthesis though this mechanism cannot explain increases in central fatigue observed following fat ingestion (Wells et al, 1995; Cunliffe et al, 1997a) which does not increase this ratio.
